| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.26e-18 | 67 | 127 | 14 | GO:0031492 |
| GeneOntologyMolecularFunction | chromatin DNA binding | FOXO1 FOXO3 H2AC11 H2AZ2 H2AC21 JMJD1C H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.05e-16 | 167 | 127 | 17 | GO:0031490 |
| GeneOntologyMolecularFunction | nucleosome binding | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.77e-15 | 98 | 127 | 14 | GO:0031491 |
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.37e-15 | 100 | 127 | 14 | GO:0030527 |
| GeneOntologyMolecularFunction | chromatin binding | NELFE FOXO1 FOXO3 H2AC11 ZNF609 H2AZ2 STAG1 H2AC21 POU4F2 TFAP2A JMJD1C ZNF750 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 KMT5B H2AC1 H2AC7 H2AX H2AZ1 H2AJ NFAT5 STAG3 H2AC12 BAHCC1 | 1.24e-13 | 739 | 127 | 27 | GO:0003682 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2AC11 PDSS2 H2AZ2 BARD1 H2AC21 KCNB2 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.00e-09 | 398 | 127 | 16 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | H2AC11 MYL5 H2AZ2 MAP4 H2AC21 SRBD1 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 LLGL1 H2AC1 H2AC7 H2AX H2AZ1 MACF1 H2AJ RIMS1 RIMS2 H2AC12 | 2.00e-07 | 891 | 127 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.39e-04 | 4 | 127 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.10e-03 | 8 | 127 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.10e-03 | 8 | 127 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.40e-03 | 9 | 127 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | protein dimerization activity | H2AC11 PDSS2 H2AZ2 BARD1 H2AC21 KCNB2 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 ALPP | 1.64e-03 | 1205 | 127 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.67e-03 | 37 | 127 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.75e-03 | 10 | 127 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.75e-03 | 10 | 127 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.95e-03 | 83 | 127 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 2.13e-03 | 11 | 127 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 2.13e-03 | 11 | 127 | 2 | GO:0043995 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.35e-12 | 163 | 126 | 14 | GO:0031507 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.67e-11 | 203 | 126 | 14 | GO:0045814 |
| GeneOntologyBiologicalProcess | chromatin organization | H2AC11 BRPF3 H2AZ2 BCORL1 H2AC21 JMJD1C KMT2C H2AC6 H2AC4 H1-8 H2AC18 H2AC20 KMT2D KMT5B H2AC1 TONSL HLTF H2AC7 H2AX H2AZ1 ING4 H2AJ NFAT5 H2AC12 BAHCC1 | 1.58e-10 | 896 | 126 | 25 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2AC11 BRPF3 H2AZ2 H2AC21 JMJD1C KMT2C H2AC6 H2AC4 H1-8 H2AC18 H2AC20 KMT2D KMT5B H2AC1 HLTF H2AC7 H2AX H2AZ1 ING4 H2AJ NFAT5 H2AC12 | 7.37e-10 | 741 | 126 | 22 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2AC11 BRPF3 H2AZ2 BCORL1 H2AC21 JMJD1C KMT2C H2AC6 H2AC4 H1-8 H2AC18 H2AC20 KMT2D KMT5B H2AC1 TONSL HLTF H2AC7 H2AX H2AZ1 ING4 H2AJ NFAT5 H2AC12 BAHCC1 | 1.50e-09 | 999 | 126 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 KMT2D H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.74e-09 | 330 | 126 | 15 | GO:0040029 |
| GeneOntologyBiologicalProcess | epithelial tube formation | 1.13e-05 | 173 | 126 | 8 | GO:0072175 | |
| GeneOntologyBiologicalProcess | neural tube formation | 1.85e-05 | 134 | 126 | 7 | GO:0001841 | |
| GeneOntologyBiologicalProcess | tube formation | 1.98e-05 | 187 | 126 | 8 | GO:0035148 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 2.22e-05 | 190 | 126 | 8 | GO:0016331 | |
| GeneOntologyBiologicalProcess | neural tube development | 3.45e-05 | 202 | 126 | 8 | GO:0021915 | |
| GeneOntologyBiologicalProcess | oculomotor nerve morphogenesis | 3.70e-05 | 2 | 126 | 2 | GO:0021622 | |
| GeneOntologyBiologicalProcess | oculomotor nerve formation | 3.70e-05 | 2 | 126 | 2 | GO:0021623 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 5.55e-05 | 159 | 126 | 7 | GO:0001838 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 1.18e-04 | 16 | 126 | 3 | GO:0061029 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 1.42e-04 | 17 | 126 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | preganglionic parasympathetic fiber development | 2.01e-04 | 19 | 126 | 3 | GO:0021783 | |
| GeneOntologyBiologicalProcess | parasympathetic nervous system development | 3.15e-04 | 22 | 126 | 3 | GO:0048486 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 3.56e-04 | 55 | 126 | 4 | GO:0060071 | |
| GeneOntologyBiologicalProcess | oculomotor nerve development | 3.66e-04 | 5 | 126 | 2 | GO:0021557 | |
| GeneOntologyCellularComponent | nucleosome | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.12e-13 | 138 | 126 | 14 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | NELFE FOXO1 FOXO3 H2AC11 BRPF3 H2AZ2 STAG1 H2AC21 POU4F2 XPC TFAP2A JMJD1C H2AC6 H2AC4 PHOX2A H1-8 H2AC18 H2AC20 H2AC1 NFIL3 TONSL H2AC7 H2AX H2AZ1 TMPO ING4 H2AJ NFAT5 STAG3 H2AC12 | 2.76e-09 | 1480 | 126 | 30 | GO:0000785 |
| GeneOntologyCellularComponent | cytoplasmic region | MAP4 GRIA2 DNAI3 KIF3A STAU1 UNC13C RIMS1 RIMS2 HYDIN DYNC1H1 | 6.65e-05 | 360 | 126 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | EPS8 MYO1A LLGL1 MACF1 UNC13C STK39 RIMS1 RIMS2 DYNC1H1 SPINK5 | 8.53e-05 | 371 | 126 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | presynaptic active zone | 2.15e-04 | 141 | 126 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 3.47e-04 | 23 | 126 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | postsynaptic density | EPS8 MAP4 PRICKLE1 GRIA2 GRIA3 USP8 MIB1 PRICKLE2 MACF1 RIMS1 | 4.11e-04 | 451 | 126 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | postsynapse | EPS8 ABL2 TRIO MAP4 PRICKLE1 GRIA2 GRIA3 KIF3A MYL7 USP8 SLC9A5 MIB1 PRICKLE2 MACF1 RIMS1 PCDH8 | 4.14e-04 | 1018 | 126 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPS8 ABL2 TRIO PRICKLE1 GRIA2 GRIA3 KIF3A STAU1 USP8 MIB1 PRICKLE2 RIMS1 RIMS2 PCDH8 | 4.15e-04 | 817 | 126 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | myosin complex | 4.43e-04 | 59 | 126 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | germ cell nucleus | 6.13e-04 | 113 | 126 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | asymmetric synapse | EPS8 MAP4 PRICKLE1 GRIA2 GRIA3 USP8 MIB1 PRICKLE2 MACF1 RIMS1 | 6.34e-04 | 477 | 126 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | female germ cell nucleus | 8.50e-04 | 31 | 126 | 3 | GO:0001674 | |
| GeneOntologyCellularComponent | postsynaptic specialization | EPS8 MAP4 PRICKLE1 GRIA2 GRIA3 USP8 MIB1 PRICKLE2 MACF1 RIMS1 | 9.51e-04 | 503 | 126 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | axon | EPS8 MYO1A MYCBP2 MAP4 GRIA2 GRIA3 PTCH1 KIF3A ARHGAP4 LLGL1 C4A UNC13C C4B DYNC1H1 | 9.70e-04 | 891 | 126 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | symbiont cell surface | 9.86e-04 | 8 | 126 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 9.86e-04 | 8 | 126 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | other organism part | 1.26e-03 | 9 | 126 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPS8 MAP4 PRICKLE1 GRIA2 GRIA3 USP8 MIB1 PRICKLE2 MACF1 RIMS1 | 1.27e-03 | 523 | 126 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | cohesin complex | 1.91e-03 | 11 | 126 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | dendrite | ABL2 GPR37 GRIA2 GRIA3 PTCH1 KCNB2 STAU1 MYL7 USP8 SLC9A5 C4A C4B PCDH8 | 2.04e-03 | 858 | 126 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ABL2 GPR37 GRIA2 GRIA3 PTCH1 KCNB2 STAU1 MYL7 USP8 SLC9A5 C4A C4B PCDH8 | 2.08e-03 | 860 | 126 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.29e-03 | 12 | 126 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.52e-03 | 45 | 126 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | cell cortex region | 2.52e-03 | 45 | 126 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ABL2 MYO1A GPR37 GRIA2 GRIA3 PTCH1 KCNB2 KIF3A STAU1 MYL7 USP8 SLC9A5 C4A C4B PCDH8 DYNC1H1 | 2.92e-03 | 1228 | 126 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.94e-03 | 161 | 126 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 3.13e-03 | 14 | 126 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.13e-03 | 317 | 126 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 3.41e-03 | 50 | 126 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | dendritic spine | 3.51e-03 | 242 | 126 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 3.88e-03 | 247 | 126 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.09e-03 | 16 | 126 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 4.44e-03 | 110 | 126 | 4 | GO:0120111 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 4.70e-03 | 56 | 126 | 3 | GO:0008023 | |
| Domain | HISTONE_H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.17e-24 | 21 | 126 | 13 | PS00046 |
| Domain | Histone_H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.43e-23 | 23 | 126 | 13 | IPR002119 |
| Domain | H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.43e-23 | 23 | 126 | 13 | SM00414 |
| Domain | Histone_H2A_CS | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.13e-21 | 15 | 126 | 11 | IPR032458 |
| Domain | Histone_H2A_C | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.01e-20 | 17 | 126 | 11 | IPR032454 |
| Domain | Histone_H2A_C | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.01e-20 | 17 | 126 | 11 | PF16211 |
| Domain | Histone_H2A/H2B/H3 | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 4.70e-17 | 56 | 126 | 13 | IPR007125 |
| Domain | Histone | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 4.70e-17 | 56 | 126 | 13 | PF00125 |
| Domain | Histone-fold | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.13e-14 | 83 | 126 | 13 | IPR009072 |
| Domain | - | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.11e-12 | 69 | 126 | 11 | 1.10.20.10 |
| Domain | FOXO_KIX-bd | 4.52e-05 | 2 | 126 | 2 | IPR032068 | |
| Domain | FOXO_KIX_bdg | 4.52e-05 | 2 | 126 | 2 | PF16675 | |
| Domain | LIM3_prickle | 1.35e-04 | 3 | 126 | 2 | IPR033727 | |
| Domain | LIM2_prickle | 1.35e-04 | 3 | 126 | 2 | IPR033726 | |
| Domain | PET_prickle | 1.35e-04 | 3 | 126 | 2 | IPR033723 | |
| Domain | FOXO-TAD | 1.35e-04 | 3 | 126 | 2 | IPR032067 | |
| Domain | FOXO-TAD | 1.35e-04 | 3 | 126 | 2 | PF16676 | |
| Domain | - | BRPF3 MYCBP2 BARD1 KMT2C KMT2D ZNRF3 MIB1 HLTF ING4 RIMS1 RIMS2 | 2.33e-04 | 449 | 126 | 11 | 3.30.40.10 |
| Domain | DSRM | 2.68e-04 | 19 | 126 | 3 | SM00358 | |
| Domain | SCD | 2.69e-04 | 4 | 126 | 2 | PS51425 | |
| Domain | SCD | 2.69e-04 | 4 | 126 | 2 | IPR020839 | |
| Domain | STAG | 2.69e-04 | 4 | 126 | 2 | PF08514 | |
| Domain | STAG | 2.69e-04 | 4 | 126 | 2 | IPR013721 | |
| Domain | Znf_RING/FYVE/PHD | BRPF3 MYCBP2 BARD1 KMT2C KMT2D ZNRF3 MIB1 HLTF ING4 RIMS1 RIMS2 | 2.81e-04 | 459 | 126 | 11 | IPR013083 |
| Domain | dsrm | 3.14e-04 | 20 | 126 | 3 | PF00035 | |
| Domain | DS_RBD | 3.65e-04 | 21 | 126 | 3 | PS50137 | |
| Domain | EPHD | 4.20e-04 | 22 | 126 | 3 | PS51805 | |
| Domain | FYrich_C | 4.46e-04 | 5 | 126 | 2 | IPR003889 | |
| Domain | FYrich_N | 4.46e-04 | 5 | 126 | 2 | IPR003888 | |
| Domain | FYRC | 4.46e-04 | 5 | 126 | 2 | SM00542 | |
| Domain | FYRN | 4.46e-04 | 5 | 126 | 2 | SM00541 | |
| Domain | Anaphylatoxin_comp_syst | 4.46e-04 | 5 | 126 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.46e-04 | 5 | 126 | 2 | IPR001840 | |
| Domain | FYRN | 4.46e-04 | 5 | 126 | 2 | PF05964 | |
| Domain | FYRC | 4.46e-04 | 5 | 126 | 2 | PF05965 | |
| Domain | FYRC | 4.46e-04 | 5 | 126 | 2 | PS51543 | |
| Domain | FYRN | 4.46e-04 | 5 | 126 | 2 | PS51542 | |
| Domain | Znf_FYVE_PHD | 4.87e-04 | 147 | 126 | 6 | IPR011011 | |
| Domain | PET | 6.65e-04 | 6 | 126 | 2 | PF06297 | |
| Domain | PET_domain | 6.65e-04 | 6 | 126 | 2 | IPR010442 | |
| Domain | PET | 6.65e-04 | 6 | 126 | 2 | PS51303 | |
| Domain | - | 7.79e-04 | 27 | 126 | 3 | 3.30.160.20 | |
| Domain | dsRBD_dom | 8.68e-04 | 28 | 126 | 3 | IPR014720 | |
| Domain | ANATO | 9.27e-04 | 7 | 126 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 9.27e-04 | 7 | 126 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 9.27e-04 | 7 | 126 | 2 | PS01177 | |
| Domain | ANATO | 9.27e-04 | 7 | 126 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 9.27e-04 | 7 | 126 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.23e-03 | 8 | 126 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.23e-03 | 8 | 126 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.23e-03 | 8 | 126 | 2 | IPR019742 | |
| Domain | PHD | 1.66e-03 | 75 | 126 | 4 | PF00628 | |
| Domain | A2M | 1.96e-03 | 10 | 126 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.96e-03 | 10 | 126 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.96e-03 | 10 | 126 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.96e-03 | 10 | 126 | 2 | PF07677 | |
| Domain | A2M_comp | 1.96e-03 | 10 | 126 | 2 | PF07678 | |
| Domain | A2M_N | 1.96e-03 | 10 | 126 | 2 | PF01835 | |
| Domain | A2M_N | 1.96e-03 | 10 | 126 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.96e-03 | 10 | 126 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.96e-03 | 10 | 126 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.96e-03 | 10 | 126 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.96e-03 | 10 | 126 | 2 | IPR001599 | |
| Domain | Znf_PHD-finger | 2.01e-03 | 79 | 126 | 4 | IPR019787 | |
| Domain | FYVE_2 | 2.39e-03 | 11 | 126 | 2 | PF02318 | |
| Domain | SET | 2.65e-03 | 41 | 126 | 3 | PF00856 | |
| Domain | RABBD | 2.85e-03 | 12 | 126 | 2 | PS50916 | |
| Domain | Rab_BD | 2.85e-03 | 12 | 126 | 2 | IPR010911 | |
| Domain | PHD | 3.10e-03 | 89 | 126 | 4 | SM00249 | |
| Domain | Znf_PHD | 3.36e-03 | 91 | 126 | 4 | IPR001965 | |
| Domain | Ank_2 | 3.40e-03 | 215 | 126 | 6 | PF12796 | |
| Domain | SH3 | 3.48e-03 | 216 | 126 | 6 | PS50002 | |
| Domain | SET | 3.68e-03 | 46 | 126 | 3 | SM00317 | |
| Domain | SH3_domain | 3.81e-03 | 220 | 126 | 6 | IPR001452 | |
| Domain | ZF_PHD_2 | 3.92e-03 | 95 | 126 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 4.07e-03 | 96 | 126 | 4 | PS01359 | |
| Domain | ZF_RING_2 | 4.12e-03 | 298 | 126 | 7 | PS50089 | |
| Domain | OTU | 4.48e-03 | 15 | 126 | 2 | PS50802 | |
| Domain | OTU_dom | 4.48e-03 | 15 | 126 | 2 | IPR003323 | |
| Domain | Ank | 4.53e-03 | 228 | 126 | 6 | PF00023 | |
| Domain | SET_dom | 4.66e-03 | 50 | 126 | 3 | IPR001214 | |
| Domain | SET | 4.66e-03 | 50 | 126 | 3 | PS50280 | |
| Domain | RING | 4.67e-03 | 305 | 126 | 7 | SM00184 | |
| Domain | Post-SET_dom | 5.09e-03 | 16 | 126 | 2 | IPR003616 | |
| Domain | PostSET | 5.09e-03 | 16 | 126 | 2 | SM00508 | |
| Domain | POST_SET | 5.09e-03 | 16 | 126 | 2 | PS50868 | |
| Domain | C345C | 5.75e-03 | 17 | 126 | 2 | SM00643 | |
| Domain | Lig_chan-Glu_bd | 6.44e-03 | 18 | 126 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.44e-03 | 18 | 126 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.44e-03 | 18 | 126 | 2 | SM00918 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.44e-03 | 18 | 126 | 2 | IPR008930 | |
| Domain | Iontro_rcpt | 6.44e-03 | 18 | 126 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.44e-03 | 18 | 126 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.44e-03 | 18 | 126 | 2 | PF00060 | |
| Domain | PBPe | 6.44e-03 | 18 | 126 | 2 | SM00079 | |
| Domain | Znf_RING | 6.67e-03 | 326 | 126 | 7 | IPR001841 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | H2AC11 BARD1 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 1.49e-15 | 37 | 104 | 11 | M27580 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 C4A C4B H2AJ H2AC12 | 4.21e-15 | 139 | 104 | 16 | M4741 |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.31e-14 | 78 | 104 | 13 | M27234 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2AC11 BRPF3 H2AZ2 H2AC21 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D KMT5B H2AC1 H2AC7 H2AX ING4 H2AJ H2AC12 | 1.18e-12 | 272 | 104 | 18 | M29619 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2AZ2 STAG1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ STAG3 | 1.06e-11 | 78 | 104 | 11 | M1061 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 2.52e-11 | 29 | 104 | 8 | MM15291 | |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 5.37e-11 | 67 | 104 | 10 | M27342 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AJ | 1.08e-10 | 96 | 104 | 11 | M27792 |
| Pathway | REACTOME_UCH_PROTEINASES | H2AC11 BARD1 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 2.10e-10 | 102 | 104 | 11 | M27576 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | 2.18e-10 | 55 | 104 | 9 | M29526 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2AC11 NUP50 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 DYNC1H1 H2AC12 | 3.83e-10 | 138 | 104 | 12 | M29805 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2AC11 BRPF3 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 ING4 H2AC12 | 5.35e-10 | 142 | 104 | 12 | M27233 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 6.68e-10 | 62 | 104 | 9 | M27700 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2AC11 NUP50 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 8.50e-10 | 116 | 104 | 11 | M29806 |
| Pathway | REACTOME_DNA_METHYLATION | 8.96e-10 | 64 | 104 | 9 | M27429 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 9.50e-10 | 44 | 104 | 8 | MM15527 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 1.08e-09 | 90 | 104 | 10 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 1.08e-09 | 90 | 104 | 10 | M29668 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | 1.19e-09 | 66 | 104 | 9 | M27488 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AJ | 1.20e-09 | 91 | 104 | 10 | M27101 |
| Pathway | REACTOME_MEIOSIS | H2AZ2 STAG1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ STAG3 | 1.22e-09 | 120 | 104 | 11 | M529 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.37e-09 | 67 | 104 | 9 | M39003 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AJ | 1.46e-09 | 122 | 104 | 11 | M29689 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 1.56e-09 | 68 | 104 | 9 | M27658 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 1.66e-09 | 94 | 104 | 10 | M27230 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | 2.04e-09 | 70 | 104 | 9 | M48261 | |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 2.04e-09 | 70 | 104 | 9 | M48028 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 2.20e-09 | 31 | 104 | 7 | MM17225 | |
| Pathway | REACTOME_HCMV_INFECTION | H2AC11 NUP50 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 DYNC1H1 H2AC12 | 2.45e-09 | 162 | 104 | 12 | M29804 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 2.64e-09 | 72 | 104 | 9 | M29714 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 2.64e-09 | 72 | 104 | 9 | M27132 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.99e-09 | 73 | 104 | 9 | M27166 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 3.82e-09 | 75 | 104 | 9 | M27343 | |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | FOXO3 H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 4.51e-09 | 104 | 104 | 10 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 4.96e-09 | 105 | 104 | 10 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | NUP50 H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 5.44e-09 | 106 | 104 | 10 | M27458 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 6.11e-09 | 79 | 104 | 9 | M27191 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 6.54e-09 | 108 | 104 | 10 | M27426 |
| Pathway | REACTOME_MITOTIC_PROPHASE | NUP50 H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMPO H2AJ | 7.35e-09 | 142 | 104 | 11 | M27660 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ TAF1D | 7.82e-09 | 110 | 104 | 10 | M27696 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | FOXO3 H2AZ2 STAG1 CXXC5 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 EGF H2AC7 H2AX H2AJ | 8.00e-09 | 220 | 104 | 13 | M27794 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 8.32e-09 | 37 | 104 | 7 | MM14883 | |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AZ1 H2AJ | 9.32e-09 | 112 | 104 | 10 | M48334 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.01e-08 | 38 | 104 | 7 | MM15434 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2AZ2 STAG1 CXXC5 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 1.22e-08 | 149 | 104 | 11 | M27888 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.23e-08 | 39 | 104 | 7 | MM14850 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.48e-08 | 40 | 104 | 7 | MM14936 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 1.61e-08 | 88 | 104 | 9 | M1011 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 1.78e-08 | 89 | 104 | 9 | M27943 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.96e-08 | 90 | 104 | 9 | M2158 | |
| Pathway | REACTOME_REPRODUCTION | H2AZ2 STAG1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ STAG3 | 2.25e-08 | 158 | 104 | 11 | M26956 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.62e-08 | 93 | 104 | 9 | M27487 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MAPKAPK3 H2AC7 H2AX H2AJ | 2.70e-08 | 125 | 104 | 10 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 3.39e-08 | 128 | 104 | 10 | M48019 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 3.80e-08 | 97 | 104 | 9 | M48262 | |
| Pathway | REACTOME_DEUBIQUITINATION | H2AC11 BARD1 H2AC21 OTUD7B H2AC14 USP8 H2AC6 H2AC4 OTUB2 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 3.95e-08 | 299 | 104 | 14 | M27574 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D KMT5B H2AC1 ING4 H2AJ | 6.47e-08 | 175 | 104 | 11 | MM14941 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | NUP50 H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 7.44e-08 | 139 | 104 | 10 | M715 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 7.47e-08 | 50 | 104 | 7 | MM15308 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 8.98e-08 | 107 | 104 | 9 | M48260 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 1.23e-07 | 111 | 104 | 9 | M27187 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.29e-07 | 54 | 104 | 7 | MM14904 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 1.33e-07 | 112 | 104 | 9 | M4052 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2AZ2 H2AC14 USP8 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D ZNRF3 H2AC7 H2AX H2AJ | 1.42e-07 | 233 | 104 | 12 | M27099 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 1.47e-07 | 55 | 104 | 7 | MM14932 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.67e-07 | 56 | 104 | 7 | MM17236 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.25e-07 | 119 | 104 | 9 | M607 | |
| Pathway | REACTOME_UCH_PROTEINASES | 2.41e-07 | 87 | 104 | 8 | MM15287 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | FOXO3 H2AZ2 STAG1 CXXC5 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 EGF H2AC7 H2AX H2AJ | 2.62e-07 | 296 | 104 | 13 | M27869 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AJ TAF1D | 3.60e-07 | 254 | 104 | 12 | M27131 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 4.49e-07 | 129 | 104 | 9 | M27795 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 5.87e-07 | 67 | 104 | 7 | MM15429 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2AC11 H2AC21 H2AC14 USP8 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 6.81e-07 | 221 | 104 | 11 | M27578 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 7.02e-07 | 136 | 104 | 9 | MM14848 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 8.44e-07 | 139 | 104 | 9 | M868 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2AZ2 PRICKLE1 H2AC14 USP8 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D ZNRF3 H2AC7 H2AX H2AJ | 9.02e-07 | 330 | 104 | 13 | M7847 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.01e-06 | 142 | 104 | 9 | M48257 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 1.16e-06 | 74 | 104 | 7 | MM14605 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AJ | 1.36e-06 | 237 | 104 | 11 | M27786 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 1.47e-06 | 110 | 104 | 8 | M27958 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MAPKAPK3 H2AC7 H2AX H2AJ | 1.89e-06 | 197 | 104 | 10 | M27188 |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.93e-06 | 114 | 104 | 8 | MM15361 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 EGF MIB1 H2AC7 H2AX H2AJ | 1.95e-06 | 246 | 104 | 11 | M10189 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 2.59e-06 | 159 | 104 | 9 | M27665 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 2.67e-06 | 119 | 104 | 8 | MM14901 | |
| Pathway | REACTOME_DEUBIQUITINATION | BARD1 H2AC21 OTUD7B USP8 H2AC6 H2AC4 OTUB2 H2AC18 H2AC20 H2AC1 H2AJ | 3.59e-06 | 262 | 104 | 11 | MM15286 |
| Pathway | REACTOME_DNA_REPLICATION | 9.75e-06 | 187 | 104 | 9 | M1017 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.01e-05 | 102 | 104 | 7 | MM15430 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | NELFE FOXO1 FOXO3 BRPF3 ELOA2 H2AZ2 BARD1 POU4F2 TFAP2A ZNF750 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D ZNF764 H2AX H2AJ | 1.17e-05 | 768 | 104 | 18 | MM14851 |
| Pathway | REACTOME_M_PHASE | NUP50 H2AZ2 STAG1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMPO H2AJ DYNC1H1 | 1.17e-05 | 417 | 104 | 13 | M27662 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.71e-05 | 153 | 104 | 8 | MM15522 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | H2AC11 NUP50 STAG1 BARD1 H2AC21 XPC FEM1C F5 TFAP2A GFPT1 OTUD7B H2AC14 USP8 H2AC6 H2AC4 OTUB2 H2AC18 H2AC20 IGFBP5 H2AC1 HLTF H2AC7 C4A EIF2AK2 DYNC1H1 H2AC12 | 1.81e-05 | 1475 | 104 | 26 | M19806 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2AZ2 WIPF1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ DYNC1H1 | 2.58e-05 | 323 | 104 | 11 | M27080 |
| Pathway | REACTOME_DNA_REPAIR | H2AZ2 BARD1 XPC H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 3.32e-05 | 332 | 104 | 11 | M15434 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | NELFE FOXO1 FOXO3 NUP50 BRPF3 ELOA2 H2AZ2 BARD1 POU4F2 TFAP2A ZNF750 H2AC6 H2AC4 H2AC18 H2AC20 KMT2D ZNF764 H2AX H2AJ TAF1D | 4.91e-05 | 1022 | 104 | 20 | MM15436 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ABL2 H2AZ2 WIPF1 TRIO ARHGAP4 H2AC14 ARHGAP6 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMPO H2AJ DYNC1H1 | 7.16e-05 | 720 | 104 | 16 | M41838 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 8.33e-05 | 191 | 104 | 8 | MM15289 | |
| Pathway | WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA | 9.70e-05 | 33 | 104 | 4 | M39800 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | NUP50 STAG1 BARD1 H2AC21 XPC FEM1C F5 GFPT1 OTUD7B USP8 H2AC6 H2AC4 OTUB2 H2AC18 H2AC20 IGFBP5 H2AC1 HLTF C4A C4B H2AJ DYNC1H1 ALPP | 1.61e-04 | 1389 | 104 | 23 | MM15307 |
| Pathway | REACTOME_CELL_CYCLE | NUP50 H2AZ2 STAG1 BARD1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMPO H2AJ STAG3 DYNC1H1 | 1.67e-04 | 694 | 104 | 15 | M543 |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.87e-21 | 69 | 129 | 14 | 11689053 |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.39e-20 | 73 | 129 | 14 | 14657027 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.39e-20 | 73 | 129 | 14 | 9566873 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.70e-20 | 74 | 129 | 14 | 36180920 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.63e-19 | 86 | 129 | 14 | 11080476 | |
| Pubmed | Precise characterization of human histones in the H2A gene family by top down mass spectrometry. | 8.47e-17 | 14 | 129 | 8 | 16457589 | |
| Pubmed | 1.34e-15 | 30 | 129 | 9 | 16319397 | ||
| Pubmed | DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. | 2.67e-15 | 11 | 129 | 7 | 16702407 | |
| Pubmed | 2.67e-15 | 11 | 129 | 7 | 15078818 | ||
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AC12 | 6.42e-15 | 77 | 129 | 11 | 12408966 | |
| Pubmed | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. | 1.38e-14 | 13 | 129 | 7 | 15823041 | |
| Pubmed | H2AC11 H2AC21 H2AC14 H2AC6 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.97e-14 | 88 | 129 | 11 | 26318153 | |
| Pubmed | 9.11e-14 | 16 | 129 | 7 | 15386022 | ||
| Pubmed | Phosphorylation of histone H2A inhibits transcription on chromatin templates. | 2.52e-13 | 18 | 129 | 7 | 15010469 | |
| Pubmed | Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. | 3.98e-13 | 19 | 129 | 7 | 16359901 | |
| Pubmed | ELOA2 H2AZ2 MYH13 MYO1A STAG1 H2AC21 GRIA2 GRIA3 XPC SRBD1 LUZP1 H2AC14 USP8 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO MACF1 H2AJ RIMS1 RIMS2 H2AC12 BAHCC1 | 4.64e-13 | 1442 | 129 | 28 | 35575683 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 GFPT1 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 MACF1 C4A C4B STK39 H2AJ EIF2AK2 DYNC1H1 H2AC12 | 7.06e-13 | 844 | 129 | 22 | 25963833 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | H2AC11 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AJ H2AC12 | 2.02e-11 | 116 | 129 | 10 | 22810585 |
| Pubmed | Quantitative determination of histone modification. H2A acetylation and phosphorylation. | 1.81e-10 | 4 | 129 | 4 | 7217105 | |
| Pubmed | H2AZ2 TRIO MAP4 H2AC21 H2AC14 ARHGAP6 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AJ H2AC12 | 8.91e-10 | 513 | 129 | 15 | 25798074 | |
| Pubmed | 1.43e-09 | 55 | 129 | 7 | 9439656 | ||
| Pubmed | 2.69e-09 | 6 | 129 | 4 | 15509584 | ||
| Pubmed | NELFE NUP50 ZNF609 WIPF1 MYCBP2 MAP4 BCORL1 GTPBP1 TFAP2A JMJD1C STAU1 KMT2C H2AC20 KMT2D NFIL3 CIAPIN1 HLTF TMPO METAP2 DYNC1H1 | 4.80e-09 | 1103 | 129 | 20 | 34189442 | |
| Pubmed | Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. | 6.27e-09 | 7 | 129 | 4 | 16699504 | |
| Pubmed | H2AC11 H2AZ2 MAP4 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 MACF1 H2AJ COIL EIF2AK2 DYNC1H1 H2AC12 | 1.01e-08 | 1153 | 129 | 20 | 29845934 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 OTUB2 H2AC18 H2AC20 TSBP1 H2AC1 H2AC7 H2AX H2AZ1 | 1.05e-08 | 438 | 129 | 13 | 21630459 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2AC11 LUZP1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 C4A C4B H2AJ DYNC1H1 H2AC12 | 2.87e-08 | 477 | 129 | 13 | 31300519 |
| Pubmed | Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers. | 3.73e-08 | 10 | 129 | 4 | 25731851 | |
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 4.99e-08 | 3 | 129 | 3 | 22183980 | |
| Pubmed | 5.84e-08 | 11 | 129 | 4 | 25362550 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUP50 ZNF609 H2AZ2 BCORL1 CXXC5 BARD1 XPC ZNF395 SRBD1 TFAP2A JMJD1C KMT2C KMT2D NFIL3 TONSL HLTF H2AC7 TMPO ING4 COIL | 6.70e-08 | 1294 | 129 | 20 | 30804502 |
| Pubmed | 8.74e-08 | 12 | 129 | 4 | 15525528 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | H2AC11 EPS8 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC18 H2AC20 EGF H2AC1 H2AC7 H2AX H2AZ1 C4A C4B H2AJ DYNC1H1 H2AC12 | 9.36e-08 | 1070 | 129 | 18 | 23533145 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.07e-07 | 281 | 129 | 10 | 28706196 | |
| Pubmed | 1.92e-07 | 67 | 129 | 6 | 25253489 | ||
| Pubmed | A previously undetected MHC gene with an unusual periodic structure. | 1.99e-07 | 4 | 129 | 3 | 3353717 | |
| Pubmed | 3.88e-07 | 247 | 129 | 9 | 30713523 | ||
| Pubmed | Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant. | 4.96e-07 | 5 | 129 | 3 | 11331621 | |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 4.96e-07 | 5 | 129 | 3 | 34706221 | |
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 20484669 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H2AC11 H2AZ2 MAP4 TFAP2A GFPT1 LUZP1 H2AC14 H2AC18 H2AC20 LLGL1 H2AC7 H2AZ1 H2AJ EIF2AK2 DYNC1H1 H2AC12 | 5.00e-07 | 949 | 129 | 16 | 36574265 |
| Pubmed | 5.31e-07 | 18 | 129 | 4 | 29743367 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NELFE ZNF609 MYCBP2 MAP4 XPC GTPBP1 TFAP2A LUZP1 STAU1 CIAPIN1 H2AX MACF1 METAP2 TAF1D | 5.46e-07 | 724 | 129 | 14 | 36232890 |
| Pubmed | NELFE MYCBP2 MAP4 TFAP2A JMJD1C LUZP1 KMT2C KMT2D CIAPIN1 TMPO COIL DYNC1H1 | 1.04e-06 | 549 | 129 | 12 | 38280479 | |
| Pubmed | TRIO MYCBP2 MAP4 GRIA2 GRIA3 KCNB2 STAU1 H2AC4 MESD H2AC18 SPHKAP PRICKLE2 H2AX MACF1 RIMS1 COIL PCDH8 | 1.15e-06 | 1139 | 129 | 17 | 36417873 | |
| Pubmed | A novel role for cilia-dependent sonic hedgehog signaling during submandibular gland development. | 1.51e-06 | 23 | 129 | 4 | 29532549 | |
| Pubmed | A tissue-specific role for intraflagellar transport genes during craniofacial development. | 1.73e-06 | 7 | 129 | 3 | 28346501 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.73e-06 | 7 | 129 | 3 | 8858345 | |
| Pubmed | Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation. | 1.73e-06 | 7 | 129 | 3 | 34321665 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.73e-06 | 7 | 129 | 3 | 36398873 | |
| Pubmed | Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. | 1.73e-06 | 7 | 129 | 3 | 11927591 | |
| Pubmed | RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. | 1.73e-06 | 7 | 129 | 3 | 22980979 | |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 36598580 | ||
| Pubmed | MAP4 GTPBP1 GFPT1 STAU1 KMT2C H2AC4 KMT2D H2AX H2AZ1 TMPO MACF1 METAP2 DYNC1H1 | 2.62e-06 | 711 | 129 | 13 | 33022573 | |
| Pubmed | A primary cilia-dependent etiology for midline facial disorders. | 2.75e-06 | 8 | 129 | 3 | 20106874 | |
| Pubmed | USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168. | 2.75e-06 | 8 | 129 | 3 | 26507658 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 2.75e-06 | 8 | 129 | 3 | 10072631 | |
| Pubmed | Unique spatiotemporal requirements for intraflagellar transport genes during forebrain development. | 2.75e-06 | 8 | 129 | 3 | 28291836 | |
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 23537390 | ||
| Pubmed | 3.01e-06 | 60 | 129 | 5 | 32027825 | ||
| Pubmed | The genomic organization of the histone clusters on human 6p21.3. | 4.12e-06 | 9 | 129 | 3 | 10384058 | |
| Pubmed | 4.12e-06 | 329 | 129 | 9 | 17474147 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2AC11 H2AZ2 MYCBP2 GFPT1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 HLTF H2AC7 H2AX H2AZ1 TMPO H2AJ DYNC1H1 H2AC12 | 4.30e-06 | 1257 | 129 | 17 | 37317656 |
| Pubmed | 4.59e-06 | 250 | 129 | 8 | 33536335 | ||
| Pubmed | 5.87e-06 | 10 | 129 | 3 | 37633270 | ||
| Pubmed | 5.87e-06 | 10 | 129 | 3 | 17698054 | ||
| Pubmed | EPS8 TRIO MAP4 GRIA2 GTPBP1 LUZP1 KIF3A STAU1 H2AC20 LRIG1 PRICKLE2 TMPO MACF1 C4A C4B RIMS1 METAP2 DYNC1H1 | 5.96e-06 | 1431 | 129 | 18 | 37142655 | |
| Pubmed | 5.99e-06 | 32 | 129 | 4 | 30532072 | ||
| Pubmed | NELFE NUP50 H2AZ2 TRIO MYCBP2 H2AC21 GFPT1 LUZP1 H2AC14 MESD MAPKAPK3 CNPY3 MACF1 EIF2AK2 METAP2 DYNC1H1 ALPP | 6.49e-06 | 1297 | 129 | 17 | 33545068 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 8.05e-06 | 11 | 129 | 3 | 34767769 | |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 8.05e-06 | 11 | 129 | 3 | 10686478 | |
| Pubmed | Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. | 8.05e-06 | 11 | 129 | 3 | 26237645 | |
| Pubmed | 9.38e-06 | 197 | 129 | 7 | 36604605 | ||
| Pubmed | 1.07e-05 | 12 | 129 | 3 | 17344228 | ||
| Pubmed | 1.07e-05 | 12 | 129 | 3 | 14759373 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE NUP50 ZNF609 H2AZ2 MAP4 BCORL1 TFAP2A JMJD1C LUZP1 STAU1 H2AC20 H2AZ1 TMPO COIL | 1.31e-05 | 954 | 129 | 14 | 36373674 |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24895270 | ||
| Pubmed | CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. | 1.37e-05 | 2 | 129 | 2 | 31504797 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.37e-05 | 2 | 129 | 2 | 16565498 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15998580 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24448243 | ||
| Pubmed | Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring. | 1.37e-05 | 2 | 129 | 2 | 25010393 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.37e-05 | 2 | 129 | 2 | 19933335 | |
| Pubmed | Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis. | 1.37e-05 | 2 | 129 | 2 | 24269635 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.37e-05 | 2 | 129 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.37e-05 | 2 | 129 | 2 | 17645767 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12207352 | ||
| Pubmed | Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. | 1.37e-05 | 2 | 129 | 2 | 16952979 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16709600 | ||
| Pubmed | Kif3a is necessary for initiation and maintenance of medulloblastoma. | 1.37e-05 | 2 | 129 | 2 | 23389290 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.37e-05 | 2 | 129 | 2 | 27758680 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.37e-05 | 2 | 129 | 2 | 23749435 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23918728 | ||
| Pubmed | Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis. | 1.37e-05 | 2 | 129 | 2 | 31756626 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.37e-05 | 2 | 129 | 2 | 3037333 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11726230 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 4216347 | ||
| Interaction | H2BC17 interactions | H2AC11 BRPF3 H2AC21 XPC ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 ING4 H2AJ H2AC12 | 2.42e-17 | 140 | 128 | 17 | int:H2BC17 |
| Interaction | H2BC21 interactions | NELFE H2AC11 NUP50 BRPF3 BCORL1 BARD1 JPH2 H2AC21 XPC SRBD1 ADARB1 TFAP2A JMJD1C H2AC14 USP8 H2AC6 H2AC4 MESD H2AC18 H2AC20 H2AC1 HLTF H2AC7 H2AX H2AZ1 ING4 H2AJ DYNC1H1 H2AC12 BAHCC1 | 4.83e-17 | 696 | 128 | 30 | int:H2BC21 |
| Interaction | H2BC18 interactions | NELFE H2AC11 H2AZ2 H2AC21 ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AJ H2AC12 | 1.77e-15 | 180 | 128 | 17 | int:H2BC18 |
| Interaction | H2BC5 interactions | H2AC11 NUP50 H2AZ2 MAP4 JPH2 H2AC21 XPC ADARB1 STAU1 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.23e-15 | 331 | 128 | 21 | int:H2BC5 |
| Interaction | LOC102724334 interactions | H2AC11 H2AZ2 H2AC21 ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.90e-15 | 134 | 128 | 15 | int:LOC102724334 |
| Interaction | H2BC15 interactions | H2AC11 JPH2 H2AC21 ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX ING4 H2AJ H2AC12 | 2.04e-14 | 144 | 128 | 15 | int:H2BC15 |
| Interaction | H2BC26 interactions | H2AC11 H2AC21 XPC ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TONSL H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 4.24e-14 | 183 | 128 | 16 | int:H2BC26 |
| Interaction | H2BC11 interactions | H2AC11 H2AZ2 H2AC21 ADARB1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AJ H2AC12 | 5.48e-14 | 186 | 128 | 16 | int:H2BC11 |
| Interaction | H2AC1 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 8.13e-13 | 71 | 128 | 11 | int:H2AC1 |
| Interaction | H2AC20 interactions | NELFE H2AC11 BARD1 XPC H2AC14 USP8 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TONSL H2AC7 H2AX H2AZ1 H2AJ EIF2AK2 H2AC12 | 2.00e-12 | 320 | 128 | 18 | int:H2AC20 |
| Interaction | H2BC12 interactions | H2AC11 H2AZ2 MAP4 JPH2 ADARB1 H2AC14 H2AC6 H2AC4 MESD H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 ANKRD36 H2AJ H2AC12 | 2.22e-12 | 322 | 128 | 18 | int:H2BC12 |
| Interaction | H2AC7 interactions | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 3.79e-12 | 107 | 128 | 12 | int:H2AC7 |
| Interaction | H2BC9 interactions | H2AC11 NUP50 H2AZ2 JPH2 H2AC21 ADARB1 ARHGAP4 H2AC14 H2AC4 MESD H1-8 H2AC18 H2AC20 H2AC7 H2AX H2AZ1 TMPO ANKRD36 COIL H2AC12 | 6.91e-12 | 446 | 128 | 20 | int:H2BC9 |
| Interaction | H3-4 interactions | H2AC11 NUP50 BRPF3 H2AZ2 JPH2 H2AC21 ZNF395 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC7 H2AX H2AZ1 ING4 H2AJ H2AC12 | 7.49e-12 | 448 | 128 | 20 | int:H3-4 |
| Interaction | H2AC4 interactions | H2AC11 BARD1 H2AC21 XPC ZNF395 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC1 TONSL HLTF H2AC7 H2AX H2AZ1 H2AJ EIF2AK2 H2AC12 | 8.44e-12 | 506 | 128 | 21 | int:H2AC4 |
| Interaction | H2BC3 interactions | H2AC11 BARD1 H2AC21 XPC ADARB1 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC1 HLTF H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.17e-11 | 406 | 128 | 19 | int:H2BC3 |
| Interaction | H2AC12 interactions | H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ COIL H2AC12 | 1.23e-11 | 118 | 128 | 12 | int:H2AC12 |
| Interaction | H2AJ interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TONSL H2AC7 ING4 H2AJ H2AC12 | 2.96e-11 | 127 | 128 | 12 | int:H2AJ |
| Interaction | H2AC6 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AZ1 H2AJ H2AC12 | 3.85e-11 | 100 | 128 | 11 | int:H2AC6 |
| Interaction | H2AC13 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 4.37e-11 | 75 | 128 | 10 | int:H2AC13 |
| Interaction | H3C15 interactions | NELFE H2AC11 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.82e-11 | 207 | 128 | 14 | int:H3C15 |
| Interaction | H2BC13 interactions | H2AC11 NUP50 H2AZ2 MAP4 JPH2 ADARB1 H2AC6 H2AC4 H2AC18 TONSL H2AC7 H2AX H2AZ1 H2AJ | 7.05e-11 | 210 | 128 | 14 | int:H2BC13 |
| Interaction | H3C1 interactions | H2AC11 NUP50 H2AZ2 STAG1 BARD1 H2AC21 XPC SRBD1 JMJD1C STAU1 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D TONSL H2AC7 H2AX H2AZ1 TMPO ING4 H2AJ DYNC1H1 H2AC12 | 7.31e-11 | 901 | 128 | 26 | int:H3C1 |
| Interaction | H2BC4 interactions | H2AC11 H2AZ2 MAP4 JPH2 ADARB1 JMJD1C KMT2C H2AC6 H2AC4 H2AC18 H2AC7 H2AX H2AZ1 TMPO H2AC12 | 1.04e-10 | 259 | 128 | 15 | int:H2BC4 |
| Interaction | H2AC25 interactions | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 UNC13C H2AJ H2AC12 | 1.39e-10 | 84 | 128 | 10 | int:H2AC25 |
| Interaction | H2AC18 interactions | H2AC11 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 CNPY3 PDZD8 H2AJ H2AC12 | 1.79e-10 | 148 | 128 | 12 | int:H2AC18 |
| Interaction | MCM5 interactions | H2AC11 H2AZ2 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TONSL H2AC7 H2AX H2AZ1 TMPO H2AJ H2AC12 | 1.42e-09 | 420 | 128 | 17 | int:MCM5 |
| Interaction | H2BC1 interactions | H2AC11 H2AZ2 H2AC21 XPC H2AC6 H2AC4 H2AC20 H2AC1 TONSL HLTF H2AX H2AZ1 | 1.51e-09 | 178 | 128 | 12 | int:H2BC1 |
| Interaction | H3-3A interactions | H2AC11 STAG1 BCORL1 BARD1 XPC SRBD1 TFAP2A JMJD1C H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D HLTF H2AC7 H2AX TMPO H2AJ METAP2 H2AC12 | 1.88e-09 | 749 | 128 | 22 | int:H3-3A |
| Interaction | H2AC14 interactions | JPH2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AJ H2AC12 | 2.01e-09 | 144 | 128 | 11 | int:H2AC14 |
| Interaction | H3-5 interactions | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ H2AC12 | 2.92e-09 | 114 | 128 | 10 | int:H3-5 |
| Interaction | H2AC21 interactions | NELFE MAP4 H2AC21 XPC H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.25e-09 | 234 | 128 | 13 | int:H2AC21 |
| Interaction | H3C14 interactions | KMT2C H2AC6 H2AC4 H2AC18 H2AC20 KMT2D H2AC7 H2AX H2AZ1 ING4 H2AC12 | 4.69e-09 | 156 | 128 | 11 | int:H3C14 |
| Interaction | HNRNPD interactions | NELFE FOXO1 H2AC11 H2AC21 ADARB1 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX ING4 H2AJ COIL DYNC1H1 H2AC12 | 2.17e-08 | 638 | 128 | 19 | int:HNRNPD |
| Interaction | H1-4 interactions | VWA3A H2AC11 NUP50 H2AZ2 H2AC21 GRIA2 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX TMPO PDZD8 MACF1 EIF2AK2 H2AC12 | 3.37e-08 | 656 | 128 | 19 | int:H1-4 |
| Interaction | MACROH2A1 interactions | H2AC11 BARD1 GRIA2 XPC ADARB1 STAU1 H2AC14 H2AC4 H2AC18 H2AC20 TONSL H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.54e-08 | 458 | 128 | 16 | int:MACROH2A1 |
| Interaction | NUMA1 interactions | FOXO1 BARD1 H2AC21 ADARB1 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC7 H2AX H2AZ1 CNPY3 PDZD8 MACF1 DYNC1H1 | 4.91e-08 | 469 | 128 | 16 | int:NUMA1 |
| Interaction | H2AC11 interactions | H2AC11 JPH2 XPC ADARB1 H2AC4 H1-8 H2AC18 H2AC20 H2AC7 H2AX H2AZ1 H2AC12 | 6.22e-08 | 248 | 128 | 12 | int:H2AC11 |
| Interaction | HMGN2 interactions | H2AC11 H2AZ2 BARD1 ARHGAP4 H2AC14 H2AC6 H2AC4 H2AC18 TMPO EIF2AK2 H2AC12 | 1.78e-07 | 222 | 128 | 11 | int:HMGN2 |
| Interaction | H1-2 interactions | NELFE H2AC11 NUP50 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 TONSL H2AC7 H2AX H2AZ1 PDZD8 EIF2AK2 H2AC12 TAF1D | 2.24e-07 | 666 | 128 | 18 | int:H1-2 |
| Interaction | H3C2 interactions | 2.48e-07 | 68 | 128 | 7 | int:H3C2 | |
| Interaction | MIER3 interactions | 2.93e-07 | 23 | 128 | 5 | int:MIER3 | |
| Interaction | MCM2 interactions | H2AC11 H2AZ2 H2AC21 GFPT1 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 TONSL H2AC7 H2AX H2AZ1 MACF1 C4A C4B STK39 H2AJ EIF2AK2 DYNC1H1 H2AC12 | 2.96e-07 | 1081 | 128 | 23 | int:MCM2 |
| Interaction | H4C9 interactions | 4.39e-07 | 108 | 128 | 8 | int:H4C9 | |
| Interaction | APLF interactions | 5.06e-07 | 47 | 128 | 6 | int:APLF | |
| Interaction | PRKCB interactions | H2AZ2 SRBD1 H2AC14 H2AC6 H2AC20 H2AC7 H2AX H2AZ1 STK39 H2AJ H2AC12 | 7.09e-07 | 255 | 128 | 11 | int:PRKCB |
| Interaction | H1-1 interactions | H2AC11 H2AC21 ADARB1 STAU1 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC7 H2AX H2AZ1 UNC13C H2AC12 | 8.11e-07 | 507 | 128 | 15 | int:H1-1 |
| Interaction | PPM1G interactions | NUP50 H2AZ2 BARD1 H2AC21 GRIA3 H2AC4 H2AC18 H2AC20 H2AX H2AZ1 H2AJ H2AC12 | 1.13e-06 | 325 | 128 | 12 | int:PPM1G |
| Interaction | XPC interactions | 1.28e-06 | 168 | 128 | 9 | int:XPC | |
| Interaction | MEPCE interactions | H2AC11 BRPF3 H2AZ2 BARD1 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 MACF1 H2AJ DYNC1H1 H2AC12 | 2.06e-06 | 859 | 128 | 19 | int:MEPCE |
| Interaction | H1-6 interactions | H2AC21 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC7 H2AX H2AC12 | 2.08e-06 | 229 | 128 | 10 | int:H1-6 |
| Interaction | H2BC10 interactions | 2.43e-06 | 61 | 128 | 6 | int:H2BC10 | |
| Interaction | HMGA1 interactions | H2AC11 BARD1 JPH2 H2AC21 XPC STAU1 H2AC6 H2AC4 H2AC18 H2AX H2AZ1 METAP2 H2AC12 | 2.74e-06 | 419 | 128 | 13 | int:HMGA1 |
| Interaction | CEBPA interactions | NELFE NUP50 ZNF609 WIPF1 STAG1 MYCBP2 MAP4 BCORL1 GTPBP1 TFAP2A JMJD1C STAU1 KMT2C H2AC20 KMT2D NFIL3 CIAPIN1 HLTF H2AZ1 TMPO MACF1 METAP2 DYNC1H1 | 3.34e-06 | 1245 | 128 | 23 | int:CEBPA |
| Interaction | HMGN4 interactions | 3.47e-06 | 100 | 128 | 7 | int:HMGN4 | |
| Interaction | H2BC8 interactions | H2AC11 NUP50 STAG1 BCORL1 BARD1 H2AC21 XPC SRBD1 H2AC6 H2AC4 H2AC18 H2AC7 H2AX H2AZ1 TMPO | 3.90e-06 | 576 | 128 | 15 | int:H2BC8 |
| Interaction | NEK4 interactions | H2AZ2 TRIO MAP4 H2AC21 H2AC14 ARHGAP6 H2AC6 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AJ H2AC12 | 4.42e-06 | 582 | 128 | 15 | int:NEK4 |
| Interaction | H2AZ1 interactions | H2AC11 H2AZ2 H2AC21 XPC SRBD1 JMJD1C H2AC6 H2AC4 H2AC20 H2AX H2AZ1 DYNC1H1 | 4.43e-06 | 371 | 128 | 12 | int:H2AZ1 |
| Interaction | DSCR9 interactions | 4.52e-06 | 147 | 128 | 8 | int:DSCR9 | |
| Interaction | H3C11 interactions | 5.26e-06 | 40 | 128 | 5 | int:H3C11 | |
| Interaction | H2AX interactions | FOXO3 H2AC11 BARD1 H2AC21 GRIA2 XPC ADARB1 STAU1 H2AC4 H2AC20 H2AC1 TONSL HLTF H2AX H2AZ1 | 5.54e-06 | 593 | 128 | 15 | int:H2AX |
| Interaction | H1-0 interactions | FOXO1 H2AC21 JMJD1C STAU1 H2AC14 H2AC6 H2AC4 H2AZ1 H2AJ H2AC12 | 5.60e-06 | 256 | 128 | 10 | int:H1-0 |
| Interaction | KAT7 interactions | 5.80e-06 | 152 | 128 | 8 | int:KAT7 | |
| Interaction | H2BC20P interactions | 6.73e-06 | 42 | 128 | 5 | int:H2BC20P | |
| Interaction | LARP7 interactions | H2AC11 H2AZ2 BARD1 H2AC21 XPC SRBD1 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ COIL EIF2AK2 DYNC1H1 H2AC12 | 6.88e-06 | 1113 | 128 | 21 | int:LARP7 |
| Interaction | SSRP1 interactions | NELFE H2AC11 H2AC21 XPC ADARB1 TFAP2A H2AC14 H2AC4 H2AC18 H2AC20 TONSL H2AX H2AZ1 ING4 H2AJ COIL | 7.24e-06 | 685 | 128 | 16 | int:SSRP1 |
| Interaction | H1-5 interactions | FOXO1 H2AC11 MAP4 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 TONSL H2AC7 PDZD8 H2AC12 | 8.07e-06 | 463 | 128 | 13 | int:H1-5 |
| Interaction | H3-3B interactions | 8.28e-06 | 114 | 128 | 7 | int:H3-3B | |
| Interaction | RNF169 interactions | 8.87e-06 | 76 | 128 | 6 | int:RNF169 | |
| Interaction | CFDP1 interactions | 1.11e-05 | 79 | 128 | 6 | int:CFDP1 | |
| Interaction | CIT interactions | H2AC11 NUP50 STAG1 H2AC21 SRBD1 GFPT1 LUZP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 HLTF H2AC7 H2AX H2AZ1 CNPY3 TMPO MACF1 H2AJ COIL EIF2AK2 STAG3 DYNC1H1 | 1.28e-05 | 1450 | 128 | 24 | int:CIT |
| Interaction | SOX7 interactions | 1.38e-05 | 82 | 128 | 6 | int:SOX7 | |
| Interaction | DIS3L interactions | 1.61e-05 | 50 | 128 | 5 | int:DIS3L | |
| Interaction | JADE3 interactions | 1.78e-05 | 51 | 128 | 5 | int:JADE3 | |
| Interaction | HEXIM1 interactions | H2AC11 H2AZ2 MAP4 H2AC21 STAU1 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 MACF1 H2AJ DYNC1H1 H2AC12 | 1.88e-05 | 913 | 128 | 18 | int:HEXIM1 |
| Interaction | CXXC1 interactions | 2.16e-05 | 132 | 128 | 7 | int:CXXC1 | |
| Interaction | H4C2 interactions | 2.36e-05 | 54 | 128 | 5 | int:H4C2 | |
| Interaction | H4C12 interactions | 2.36e-05 | 54 | 128 | 5 | int:H4C12 | |
| Interaction | XRCC5 interactions | FOXO1 BARD1 XPC TFAP2A STAU1 H2AC4 TONSL H2AX H2AZ1 TMPO PDZD8 COIL DYNC1H1 | 2.48e-05 | 515 | 128 | 13 | int:XRCC5 |
| Interaction | ELK4 interactions | 2.66e-05 | 92 | 128 | 6 | int:ELK4 | |
| Interaction | SYNGAP1 interactions | MYCBP2 MAP4 PRICKLE1 GRIA2 GRIA3 KCNB2 SPHKAP PRICKLE2 COIL DYNC1H1 | 2.70e-05 | 307 | 128 | 10 | int:SYNGAP1 |
| Interaction | SLFN11 interactions | NUP50 H2AZ2 BARD1 H2AC21 H2AC6 H2AC18 H2AC20 H2AC7 TMPO H2AJ H2AC12 | 2.86e-05 | 376 | 128 | 11 | int:SLFN11 |
| Interaction | KIF20A interactions | H2AC11 BRPF3 MYO1A H2AC21 LUZP1 STAU1 H2AC6 H2AC4 H2AC1 HLTF H2AC7 H2AX H2AZ1 TMPO PDZD8 MACF1 COIL STAG3 ALPP | 3.62e-05 | 1052 | 128 | 19 | int:KIF20A |
| Interaction | RNF168 interactions | 3.81e-05 | 98 | 128 | 6 | int:RNF168 | |
| Interaction | H2BC6 interactions | 4.63e-05 | 62 | 128 | 5 | int:H2BC6 | |
| Interaction | BOD1L1 interactions | 4.70e-05 | 149 | 128 | 7 | int:BOD1L1 | |
| Interaction | SRPK2 interactions | NELFE NUP50 MYCBP2 MAP4 BARD1 H2AC21 ADARB1 F5 JMJD1C STAU1 MAPKAPK3 TMPO MACF1 COIL TAF1D | 5.09e-05 | 717 | 128 | 15 | int:SRPK2 |
| Interaction | AGAP2 interactions | 5.97e-05 | 210 | 128 | 8 | int:AGAP2 | |
| Interaction | USP7 interactions | FOXO3 ZNF609 MYH13 BCORL1 GRIA3 XPC ADARB1 KIF3A STAU1 H2AC4 H2AC20 KMT2D EGF TSBP1 HLTF H2AX TMPO MACF1 COIL STAG3 DYNC1H1 | 7.90e-05 | 1313 | 128 | 21 | int:USP7 |
| Interaction | RPL29 interactions | 8.08e-05 | 282 | 128 | 9 | int:RPL29 | |
| Interaction | XRCC6 interactions | NELFE NUP50 EPS8 H2AZ2 MAP4 BARD1 XPC ADARB1 TFAP2A JMJD1C H2AC4 TONSL H2AX H2AZ1 TMPO PDZD8 COIL | 8.15e-05 | 928 | 128 | 17 | int:XRCC6 |
| Interaction | PARP1 interactions | FOXO1 STAG1 MYCBP2 BCORL1 BARD1 H2AC21 XPC SRBD1 TFAP2A STAU1 H2AC14 H2AC6 H2AC4 H2AC18 HLTF H2AX H2AZ1 TMPO H2AJ COIL STAG3 | 8.16e-05 | 1316 | 128 | 21 | int:PARP1 |
| Interaction | YWHAQ interactions | NELFE FOXO1 FOXO3 ABL2 MYH13 SASH1 MYCBP2 MAP4 R3HDM2 ZNF395 LUZP1 STAU1 USP8 H2AC4 KMT5B H2AX TMPO MACF1 DYNC1H1 | 8.17e-05 | 1118 | 128 | 19 | int:YWHAQ |
| Interaction | H3C6 interactions | 9.96e-05 | 226 | 128 | 8 | int:H3C6 | |
| Interaction | KLHL7 interactions | 1.02e-04 | 73 | 128 | 5 | int:KLHL7 | |
| Interaction | CEBPB interactions | NELFE FOXO1 NUP50 H2AZ2 MAP4 H2AC21 XPC LUZP1 STAU1 ARHGAP4 H2AC14 H2AC20 KMT2D NFIL3 H2AC7 H2AX H2AZ1 TMPO NFAT5 EIF2AK2 METAP2 DYNC1H1 | 1.05e-04 | 1443 | 128 | 22 | int:CEBPB |
| Interaction | DSCAM interactions | 1.12e-04 | 171 | 128 | 7 | int:DSCAM | |
| Interaction | H2AC17 interactions | 1.19e-04 | 232 | 128 | 8 | int:H2AC17 | |
| Interaction | RPL6P1 interactions | 1.20e-04 | 3 | 128 | 2 | int:RPL6P1 | |
| Interaction | HDAC2 interactions | ZNF609 STAG1 TRIO MYCBP2 MAP4 ADARB1 JMJD1C GFPT1 H2AC20 H2AC1 H2AX H2AZ1 TMPO ARRDC2 EIF2AK2 DYNC1H1 | 1.20e-04 | 865 | 128 | 16 | int:HDAC2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 1.26e-05 | 378 | 129 | 8 | chr6p22 | |
| Cytoband | 6p22.1 | 5.34e-05 | 142 | 129 | 5 | 6p22.1 | |
| Cytoband | 6p21.3 | 7.31e-04 | 250 | 129 | 5 | 6p21.3 | |
| GeneFamily | Histones | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H1-8 H2AC18 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.93e-17 | 116 | 98 | 15 | 864 |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 1.73e-04 | 4 | 98 | 2 | 1200 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 1.73e-04 | 4 | 98 | 2 | 833 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 1.73e-04 | 4 | 98 | 2 | 1184 | |
| GeneFamily | Cohesin complex | 7.97e-04 | 8 | 98 | 2 | 1060 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.18e-04 | 34 | 98 | 3 | 487 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.02e-03 | 9 | 98 | 2 | 1234 | |
| GeneFamily | PHD finger proteins | 1.45e-03 | 90 | 98 | 4 | 88 | |
| GeneFamily | Ankyrin repeat domain containing | 2.04e-03 | 242 | 98 | 6 | 403 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 2.54e-03 | 14 | 98 | 2 | 657 | |
| GeneFamily | OTU domain containing | 3.75e-03 | 17 | 98 | 2 | 669 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.04e-03 | 25 | 98 | 2 | 775 | |
| Coexpression | REN_BOUND_BY_E2F | 6.20e-07 | 62 | 129 | 6 | M4493 | |
| Coexpression | FISCHER_DREAM_TARGETS | H2AC11 NUP50 H2AZ2 STAG1 RTTN BARD1 H2AC21 H2AC14 H2AC6 H2AC4 H2AC20 TONSL HLTF H2AC7 H2AX H2AZ1 TMPO H2AC12 | 1.31e-06 | 969 | 129 | 18 | M149 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | FOXO1 FOXO3 NUP50 BRPF3 H2AZ2 WIPF1 STAG1 ZNF395 GTPBP1 JMJD1C H2AC18 TMPO PDZD8 METAP2 TAF1D | 1.35e-06 | 680 | 129 | 15 | M41089 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 5.97e-06 | 196 | 129 | 8 | M5381 | |
| Coexpression | GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN | 6.67e-06 | 199 | 129 | 8 | M3502 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 6.92e-06 | 200 | 129 | 8 | M5901 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP | 2.03e-05 | 168 | 129 | 7 | M6704 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 2.05e-05 | 304 | 129 | 9 | M39208 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN | 2.78e-05 | 119 | 129 | 6 | M8817 | |
| Coexpression | TGFB_UP.V1_DN | 4.62e-05 | 191 | 129 | 7 | M2838 | |
| Coexpression | LTE2_UP.V1_DN | 5.27e-05 | 195 | 129 | 7 | M2721 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NUP50 RTTN BARD1 XPC GTPBP1 H2AC14 H2AC4 SLC9A5 TONSL HLTF H2AX H2AZ1 H2AC12 | 5.30e-05 | 714 | 129 | 13 | M1744 |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 5.99e-05 | 199 | 129 | 7 | M7596 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 5.99e-05 | 199 | 129 | 7 | M8961 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP | 6.18e-05 | 200 | 129 | 7 | M5800 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 6.18e-05 | 200 | 129 | 7 | M107 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 6.26e-05 | 272 | 129 | 8 | M15123 | |
| Coexpression | QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR | 7.55e-05 | 88 | 129 | 5 | MM963 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 8.14e-05 | 209 | 129 | 7 | MM1058 | |
| Coexpression | DE_YY1_TARGETS_DN | 9.82e-05 | 93 | 129 | 5 | M3278 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NELFE H2AC11 NUP50 STAG1 BARD1 H2AC21 AKIP1 H2AC14 H2AC4 MESD H2AC20 MAPKAPK3 HLTF H2AX ANKRD36 COIL H2AC12 BAHCC1 | 1.26e-04 | 1363 | 129 | 18 | M45782 |
| Coexpression | LEE_BMP2_TARGETS_UP | FOXO1 FOXO3 EPS8 H2AZ2 SASH1 ZNF395 F5 ARHGAP6 OTUB2 IGFBP5 LRIG1 MAPKAPK3 RIMS1 | 1.28e-04 | 780 | 129 | 13 | M2324 |
| Coexpression | LEE_BMP2_TARGETS_UP | FOXO1 FOXO3 EPS8 H2AZ2 SASH1 ZNF395 F5 ARHGAP6 OTUB2 IGFBP5 LRIG1 MAPKAPK3 RIMS1 | 1.75e-04 | 805 | 129 | 13 | MM1067 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 2.33e-07 | 108 | 124 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 4.36e-07 | 80 | 124 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.44e-06 | 137 | 124 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.78e-06 | 110 | 124 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.32e-05 | 133 | 124 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.09e-05 | 164 | 124 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - hippocampus | 9.40e-05 | 78 | 124 | 5 | BM Top 100 - hippocampus | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AC12 | 4.10e-13 | 191 | 129 | 12 | a3c5a913a99f17633c140ec9ece81b73e59e0715 |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 H2AC12 | 8.75e-12 | 188 | 129 | 11 | be3db9768364568f44e32ae6b3bf99e49b0978bb |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 H2AC6 H2AC4 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AC12 | 8.75e-12 | 188 | 129 | 11 | b240ea20750ffb825cb5fe41d06c632233406ab6 |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 H2AC6 H2AC4 H2AC20 H2AC1 H2AC7 H2AX H2AZ1 TMPO H2AC12 | 1.04e-11 | 191 | 129 | 11 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 1.26e-09 | 111 | 129 | 8 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.06e-09 | 181 | 129 | 9 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-09 | 193 | 129 | 9 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-09 | 194 | 129 | 9 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.99e-08 | 172 | 129 | 8 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-08 | 192 | 129 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.70e-08 | 193 | 129 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.01e-07 | 194 | 129 | 8 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 195 | 129 | 8 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-07 | 196 | 129 | 8 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-07 | 198 | 129 | 8 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-07 | 198 | 129 | 8 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.28e-07 | 200 | 129 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-07 | 141 | 129 | 7 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | Lymphoid-T_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 2.04e-07 | 143 | 129 | 7 | 2fbcca395971a8452f68481282a74cec4005d1e2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-07 | 174 | 129 | 7 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-07 | 174 | 129 | 7 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-07 | 175 | 129 | 7 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.67e-07 | 180 | 129 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 181 | 129 | 7 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 181 | 129 | 7 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 186 | 129 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 186 | 129 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 188 | 129 | 7 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 190 | 129 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 195 | 129 | 7 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 195 | 129 | 7 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.71e-06 | 196 | 129 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 196 | 129 | 7 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | COVID-19_Severe|World / Disease group, lineage and cell class | 1.77e-06 | 197 | 129 | 7 | f0824f98269bdcd8463873beaf222df8f0caa468 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-06 | 197 | 129 | 7 | af10b5e6e959e2ced01ad066f906941bc4194cc3 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-06 | 197 | 129 | 7 | 3ff23b86d310ace388d2efb3ee73dd47c46f363e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-06 | 197 | 129 | 7 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-06 | 198 | 129 | 7 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.89e-06 | 199 | 129 | 7 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.89e-06 | 199 | 129 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-06 | 200 | 129 | 7 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-06 | 200 | 129 | 7 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | critical-Lymphoid-NKT-proliferating|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-06 | 200 | 129 | 7 | d698458b90bf8256fe664618ef27620aa910b02a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-06 | 128 | 129 | 6 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-06 | 138 | 129 | 6 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 142 | 129 | 6 | 7bd05d0c0ac2dee0e6cc0f3c531f9154bf300c75 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 142 | 129 | 6 | 328d08ba2712cd42bb9846ac4d7453ae165b75e2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 142 | 129 | 6 | 94774d3e598d074f48146b0b094705dc48af5a1f | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 142 | 129 | 6 | 92bf826827b3e3387ad326566556fc90c5c2f4d5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-06 | 167 | 129 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-06 | 167 | 129 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 169 | 129 | 6 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 169 | 129 | 6 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | BL-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 173 | 129 | 6 | 90700a876d997f7c0f7b3899dffcda7fdafee547 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 174 | 129 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 176 | 129 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 179 | 129 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 180 | 129 | 6 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 180 | 129 | 6 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 183 | 129 | 6 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 184 | 129 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 185 | 129 | 6 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 185 | 129 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 186 | 129 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 187 | 129 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 187 | 129 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-05 | 187 | 129 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.83e-05 | 188 | 129 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-05 | 188 | 129 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-05 | 190 | 129 | 6 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-05 | 190 | 129 | 6 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-05 | 190 | 129 | 6 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 192 | 129 | 6 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 194 | 129 | 6 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 195 | 129 | 6 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 195 | 129 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 2.24e-05 | 195 | 129 | 6 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 195 | 129 | 6 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-05 | 196 | 129 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 196 | 129 | 6 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-05 | 196 | 129 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.38e-05 | 197 | 129 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-05 | 197 | 129 | 6 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 197 | 129 | 6 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 197 | 129 | 6 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 197 | 129 | 6 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-05 | 197 | 129 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.38e-05 | 197 | 129 | 6 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-05 | 197 | 129 | 6 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-05 | 197 | 129 | 6 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 197 | 129 | 6 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 2.38e-05 | 197 | 129 | 6 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 198 | 129 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-05 | 198 | 129 | 6 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 199 | 129 | 6 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.59e-05 | 200 | 129 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| Computational | Genes in the cancer module 222. | 8.19e-07 | 22 | 89 | 5 | MODULE_222 | |
| Computational | Genes in the cancer module 89. | 4.13e-06 | 14 | 89 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 7.41e-06 | 16 | 89 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 9.63e-06 | 17 | 89 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 1.23e-05 | 18 | 89 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 168. | 2.87e-05 | 22 | 89 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 3.45e-05 | 23 | 89 | 4 | MODULE_189 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.49e-05 | 50 | 89 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 127. | 5.71e-05 | 26 | 89 | 4 | MODULE_127 | |
| Computational | TFs and nuclear. | 7.54e-04 | 237 | 89 | 8 | MODULE_252 | |
| Computational | Genes in the cancer module 198. | 8.78e-04 | 303 | 89 | 9 | MODULE_198 | |
| Computational | Genes in the cancer module 98. | NELFE BARD1 TFAP2A H2AC18 KMT2D MAPKAPK3 HLTF H2AX H2AZ1 COIL | 1.47e-03 | 393 | 89 | 10 | MODULE_98 |
| Computational | Chromatin. | 1.55e-03 | 28 | 89 | 3 | MODULE_421 | |
| Drug | N-myristoyl-rkrtlrrl | 2.19e-07 | 46 | 128 | 6 | CID003081274 | |
| Drug | CAS 1400-61-9 | 5.19e-07 | 53 | 128 | 6 | CID000004568 | |
| Drug | 5-methyl-dCTP | 6.49e-07 | 55 | 128 | 6 | CID000161376 | |
| Drug | AC1L191M | 7.07e-07 | 89 | 128 | 7 | CID000000350 | |
| Drug | AC1OCADI | 7.32e-07 | 130 | 128 | 8 | CID006914639 | |
| Drug | SK-7041 | 1.10e-06 | 60 | 128 | 6 | CID006918714 | |
| Drug | gossypol | H2AZ2 H2AC21 ZNF395 H2AC20 H2AC1 TONSL H2AX H2AZ1 H2AJ EIF2AK2 | 1.39e-06 | 247 | 128 | 10 | CID000003503 |
| Drug | fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A | 1.78e-06 | 197 | 128 | 9 | 281_UP | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.78e-06 | 197 | 128 | 9 | 2645_UP | |
| Drug | Berberine | 2.19e-06 | 202 | 128 | 9 | ctd:D001599 | |
| Drug | spermine | H2AZ2 H2AC21 GRIA2 GRIA3 PTCH1 H2AC20 EGF H2AC1 TONSL H2AX H2AZ1 H2AJ | 2.38e-06 | 394 | 128 | 12 | CID000001103 |
| Drug | CGP 41251 | 2.62e-06 | 108 | 128 | 7 | CID000104937 | |
| Drug | YM928 | 3.43e-06 | 6 | 128 | 3 | CID006918393 | |
| Drug | C04378 | 6.93e-06 | 82 | 128 | 6 | CID000440315 | |
| Drug | butyrolactone I | 8.09e-06 | 128 | 128 | 7 | CID000123740 | |
| Drug | DADS | 9.43e-06 | 131 | 128 | 7 | CID000016590 | |
| Drug | AC1L9M5N | 1.04e-05 | 133 | 128 | 7 | CID000448618 | |
| Drug | procainamide | 1.24e-05 | 190 | 128 | 8 | CID000004913 | |
| Drug | 8-bromoguanosine | 1.43e-05 | 93 | 128 | 6 | CID000092977 | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 195 | 128 | 8 | 2796_UP | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 1802_UP | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 1.61e-05 | 197 | 128 | 8 | 205_UP | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 1.73e-05 | 199 | 128 | 8 | 264_DN | |
| Drug | arsenite | H2AZ2 H2AC21 ZNF395 H2AC1 TONSL H2AX H2AZ1 STK39 H2AJ EIF2AK2 | 2.75e-05 | 347 | 128 | 10 | CID000000544 |
| Drug | fluoride | 2.85e-05 | 278 | 128 | 9 | CID000014917 | |
| Drug | AC1L9HHR | 3.25e-05 | 354 | 128 | 10 | CID000445141 | |
| Drug | MgCl2 | 3.25e-05 | 354 | 128 | 10 | CID000024584 | |
| Drug | gamma-butyrolactone | 3.36e-05 | 108 | 128 | 6 | CID000007302 | |
| Drug | AlCl3 | 4.34e-05 | 113 | 128 | 6 | CID000024012 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.35e-05 | 166 | 128 | 7 | 3290_UP | |
| Drug | gibberellin (GA | 4.35e-05 | 166 | 128 | 7 | CID000006466 | |
| Drug | mustard oil | 4.56e-05 | 114 | 128 | 6 | CID000005971 | |
| Drug | chloride | CLCA4 H2AZ2 BARD1 H2AC21 GFPT1 H2AC4 SLC9A5 H2AC1 TONSL H2AX H2AZ1 C4A STK39 H2AJ RIMS1 DYNC1H1 ALPP | 6.53e-05 | 1029 | 128 | 17 | CID000000312 |
| Drug | NaBu | 6.66e-05 | 122 | 128 | 6 | CID000052923 | |
| Drug | butane | 6.97e-05 | 123 | 128 | 6 | CID000007843 | |
| Drug | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | FOXO1 GRIA2 XPC MYL7 EGF H2AC7 H2AX UNC13C NFAT5 EIF2AK2 DYNC1H1 H2AC12 | 7.51e-05 | 558 | 128 | 12 | ctd:C072553 |
| Drug | Ro 31-8220 | 8.64e-05 | 321 | 128 | 9 | CID000005083 | |
| Drug | W7 hydrochloride | 8.70e-05 | 250 | 128 | 8 | CID000005681 | |
| Drug | hydralazine | 8.92e-05 | 186 | 128 | 7 | CID000003637 | |
| Drug | NSC401575 | 9.08e-05 | 129 | 128 | 6 | CID000003165 | |
| Drug | 2-aminothiophenol | 9.37e-05 | 3 | 128 | 2 | ctd:C005464 | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 9.86e-05 | 189 | 128 | 7 | 5936_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 191 | 128 | 7 | 5327_UP | |
| Drug | chlorambucil | 1.07e-04 | 133 | 128 | 6 | CID000002708 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 128 | 7 | 4161_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 128 | 7 | 3262_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 1.12e-04 | 193 | 128 | 7 | 5839_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HG-U133A | 1.16e-04 | 194 | 128 | 7 | 258_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 3969_DN | |
| Drug | butein; Down 200; 10uM; PC3; HG-U133A | 1.16e-04 | 194 | 128 | 7 | 582_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 128 | 7 | 3173_DN | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 128 | 7 | 2823_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; HL60; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 3076_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 6813_DN | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 7167_UP | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; HL60; HG-U133A | 1.24e-04 | 196 | 128 | 7 | 1729_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 6519_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3894_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3277_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 4266_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 4816_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 6746_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 3482_UP | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 5427_UP | |
| Drug | Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 6231_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 5337_UP | |
| Drug | phosphatidate | 1.69e-04 | 432 | 128 | 10 | CID005460104 | |
| Drug | NSC611747 | 1.73e-04 | 352 | 128 | 9 | CID000002534 | |
| Drug | LS-63783 | CLCA4 H2AZ2 JPH2 H2AC21 MYL7 EGF H2AC1 TONSL H2AX H2AZ1 C4A H2AJ PCDH8 ALPP | 1.76e-04 | 804 | 128 | 14 | CID000000231 |
| Drug | belinostat | 1.80e-04 | 50 | 128 | 4 | CID006918638 | |
| Drug | Actinomycin D | H2AZ2 GPR37 H2AC21 EGF H2AC1 TONSL H2AX H2AZ1 H2AJ COIL ALPP | 1.83e-04 | 523 | 128 | 11 | CID000002019 |
| Drug | AC1N8N2J | 1.84e-04 | 20 | 128 | 3 | CID004346372 | |
| Drug | 3-pyridazinol 1-oxide | 1.87e-04 | 4 | 128 | 2 | CID000574311 | |
| Drug | Aniracetam | 1.87e-04 | 4 | 128 | 2 | DB04599 | |
| Drug | NSC759587 | 2.10e-04 | 444 | 128 | 10 | CID000003816 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.46e-05 | 163 | 123 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy 10 (implicated_via_orthology) | 1.71e-04 | 5 | 123 | 2 | DOID:0110316 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.80e-04 | 67 | 123 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | pulmonary function measurement | 3.08e-04 | 77 | 123 | 4 | EFO_0003892 | |
| Disease | beta-defensin 119 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0801419 | |
| Disease | Neurodevelopmental Disorders | 6.30e-04 | 93 | 123 | 4 | C1535926 | |
| Disease | squamous cell lung carcinoma | 6.54e-04 | 165 | 123 | 5 | EFO_0000708 | |
| Disease | Drugs used in diabetes use measurement | 7.18e-04 | 255 | 123 | 6 | EFO_0009924 | |
| Disease | Autistic Disorder | 8.11e-04 | 261 | 123 | 6 | C0004352 | |
| Disease | Adenoid Cystic Carcinoma | 8.28e-04 | 100 | 123 | 4 | C0010606 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 8.57e-04 | 364 | 123 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Basal cell carcinoma | 9.25e-04 | 11 | 123 | 2 | C0007117 | |
| Disease | visceral adipose tissue measurement | 9.45e-04 | 481 | 123 | 8 | EFO_0004765 | |
| Disease | body fat percentage | 1.04e-03 | 488 | 123 | 8 | EFO_0007800 | |
| Disease | rac GTPase-activating protein 1 measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0801985 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.13e-03 | 49 | 123 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | complement C4 measurement | 1.35e-03 | 52 | 123 | 3 | EFO_0004984 | |
| Disease | early cardiac repolarization measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0004885 | |
| Disease | body surface area | 1.53e-03 | 643 | 123 | 9 | EFO_0022196 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.68e-03 | 121 | 123 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Malignant neoplasm of breast | BCORL1 BARD1 H2AC21 FEM1C TFAP2A KMT2D LLGL1 EGF IGFBP5 H2AX MACF1 PCDH8 | 1.80e-03 | 1074 | 123 | 12 | C0006142 |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.99e-03 | 16 | 123 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.99e-03 | 16 | 123 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Sjogren syndrome | 2.03e-03 | 60 | 123 | 3 | EFO_0000699 | |
| Disease | Intellectual Disability | 2.75e-03 | 447 | 123 | 7 | C3714756 | |
| Disease | chemerin measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0004573 | |
| Disease | receptive language perception | 2.81e-03 | 19 | 123 | 2 | EFO_0005686 | |
| Disease | Bladder Neoplasm | 2.85e-03 | 140 | 123 | 4 | C0005695 | |
| Disease | ascending aortic diameter | 2.85e-03 | 140 | 123 | 4 | EFO_0021787 | |
| Disease | Malignant neoplasm of urinary bladder | 2.92e-03 | 141 | 123 | 4 | C0005684 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.03e-03 | 69 | 123 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | colorectal adenoma (is_marker_for) | 3.12e-03 | 20 | 123 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.23e-03 | 145 | 123 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | prothrombin time measurement | 3.44e-03 | 21 | 123 | 2 | EFO_0008390 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.57e-03 | 243 | 123 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.82e-03 | 152 | 123 | 4 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSDGKKVKAVRTSLG | 1506 | Q9P281 | |
| IREKLSRAKSAKVSG | 1606 | Q9P281 | |
| VSERAKKASARSGKK | 191 | Q99728 | |
| SLRKKSRDKGQAGLQ | 741 | P0C0L5 | |
| GTAGTKVALRKTKQA | 1061 | P42684 | |
| KQGGKARAKAKTRSS | 6 | P0C0S8 | |
| KQGGKARAKAKSRSS | 6 | Q8IUE6 | |
| KQGGKARAKAKSRSS | 6 | Q16777 | |
| RGGQTASFALKKIKR | 456 | O00178 | |
| KQGGKARAKAKSRSS | 6 | Q7L7L0 | |
| KQGGKVRAKAKSRSS | 6 | Q9BTM1 | |
| GKAKAKAVSRSQRAG | 11 | Q71UI9 | |
| DIGNGQRKDRKKTSL | 131 | Q9NQ31 | |
| KGRADLKARKQKTSS | 1356 | Q5H9F3 | |
| AKSKNGGRSLREKLD | 256 | P05549 | |
| SLRAASCGEGKKRKA | 231 | Q6FI81 | |
| SGVGRRTSVLFKKAK | 921 | Q9ULD4 | |
| SRATAVKERGKNRKK | 461 | Q86Y34 | |
| SNITRGKKDGEISRK | 836 | A6QL64 | |
| LNIARGKKDGEKTRT | 1006 | A6QL64 | |
| AKLRERIKAGKGVTS | 346 | Q86YH6 | |
| NIKAGGSRSKRATLK | 436 | Q8IWG1 | |
| GARKQKRAVVASLAG | 231 | Q8TBH0 | |
| KKAKRRNVGFESDTG | 41 | Q9UKX7 | |
| KHGNRGKRQALKSAS | 841 | Q9Y2K5 | |
| RVSGKKRAANASSKL | 671 | Q15334 | |
| KKRADSVANKLGSFG | 496 | Q6GQQ9 | |
| SKRFTAIRKTKGDGN | 36 | Q96DC9 | |
| KGADVNRKSVKGNTA | 171 | Q96JP0 | |
| KSATTALGDKQRKAN | 401 | Q8IYF1 | |
| KARKTEARGLTKAGA | 636 | Q9BR39 | |
| KARKQGGAAKDTRAQ | 196 | Q8IZA3 | |
| RKAKAKGSRSSQGDA | 236 | Q8IZA3 | |
| ALSAKQRTAKKAGRE | 3211 | Q8NEZ4 | |
| GAASTAEEAAKKKRR | 26 | P50579 | |
| GGRAKVEKKTEAAAT | 951 | P27816 | |
| LLNKRRKKQAGSSSA | 361 | Q16644 | |
| RSRAAVGRKATKKTD | 86 | P42166 | |
| GNKIKSVAKRAFSGL | 391 | Q96JA1 | |
| AIKAETKNSGFKRSR | 76 | P18615 | |
| AEAVKKVNRGNGKTS | 896 | Q9UBC5 | |
| KAEARARNKRESGKA | 346 | Q9NQ38 | |
| LKSRSSKEENRAGNK | 216 | Q14696 | |
| GKDTLKAGKNAVERR | 36 | Q4FZB7 | |
| NGVLSRSAKERSKLK | 1671 | Q15652 | |
| TTAEGVARVRKSKGK | 706 | P42262 | |
| KTTADGVARVRKSKG | 716 | P42263 | |
| KTGGKARAKAKSRSS | 6 | P16104 | |
| AGTRGKVAATKQAQR | 6 | Q01449 | |
| VLRIKSAAGRKKAFN | 231 | Q8NHA6 | |
| ATTCNRRKKEVRKGG | 771 | O95206 | |
| TKKKEGGALRAQRAS | 6 | Q02045 | |
| SKRGNSTGIKLVRKE | 991 | Q8NEN9 | |
| SVGKNKSSACRRKRE | 51 | Q16649 | |
| GSARNSLVKAKRKGS | 221 | P38432 | |
| RATKSLAKGGFSEKQ | 261 | O94854 | |
| RRKKLTQSKFVGGAE | 156 | P24593 | |
| RSRAAVGRKATKKTD | 86 | P42167 | |
| RQAKTGATGQRLKEA | 256 | Q9Y496 | |
| GSGRNKKLAKARAAQ | 276 | P78563 | |
| KQGGKARAKAKSRSS | 6 | Q6FI13 | |
| EARIGIAGSKKKSTR | 396 | O94916 | |
| SGAKALGKARRKVTV | 246 | P48146 | |
| QGELASAISSGKKKR | 246 | Q7LFL8 | |
| RKSKKITARGIFAGA | 141 | Q86YT6 | |
| GGKKRRSSLSAKVVA | 1426 | Q86UR5 | |
| AASAKGFSKRKLRQT | 21 | O43182 | |
| LDRKAGGKKLRSTVQ | 1171 | Q9UQ26 | |
| NRAKKAGKSVGVVTT | 156 | P05187 | |
| SAQRKKEALGRGTIK | 101 | Q96MT3 | |
| AKESRRSAKIGKNKG | 331 | Q7Z3G6 | |
| VAAGSGARRAKRKVT | 221 | O43603 | |
| SRSRAAKKKASLQSG | 266 | Q12778 | |
| GRQAKARFKISNVGK | 3376 | Q4G0P3 | |
| KSRSLKVNFKENRGS | 711 | Q92953 | |
| ARKIRKAEKACTRGN | 466 | O15354 | |
| NALERRKNSKGQGKS | 191 | Q6ZUS6 | |
| VTSLKNDGKRTRSKG | 436 | P19525 | |
| KSLIGRSDLNGKRSK | 576 | P01133 | |
| SVKNTKRRLEGAKKA | 351 | Q96S94 | |
| KAKVTSRGKAREGRS | 641 | Q8ND61 | |
| SKKKSSRAKAAGGRS | 226 | Q9BT09 | |
| RRSSSEGLSKGKKAA | 571 | Q86V48 | |
| IRKARGTFDNAETKK | 1086 | Q14204 | |
| GKAKTKAVSRSQRAG | 11 | P0C0S5 | |
| ESAISDSKGGKQKRR | 181 | Q12929 | |
| LKNVQSETKGRAKAG | 416 | Q14527 | |
| GSRSRGASQKKQKLE | 41 | Q969F0 | |
| KQGGKARAKSKSRSS | 6 | Q96QV6 | |
| KQGGKARAKAKTRSS | 6 | P04908 | |
| KQGGKARAKAKSRSS | 6 | Q93077 | |
| KQGGKARAKAKTRSS | 6 | P20671 | |
| KQGGKARAKAKTRSS | 6 | Q96KK5 | |
| KQGGKARAKAKTRSS | 6 | Q99878 | |
| SLRKKSRDKGQAGLQ | 741 | P0C0L4 | |
| KGRTQKEKKAARARS | 131 | Q9UNL4 | |
| SNSGRFKEKKKVRAT | 71 | Q9BU68 | |
| TKSRGRAAKKKAALQ | 261 | O43524 | |
| GKSSKDILKRVAANA | 1851 | Q86VV8 | |
| CRSLKRKKESQGSGT | 976 | Q2M3C7 | |
| VRQDGGKSRLKKSQF | 1011 | P12259 | |
| RGKDKKGSCNLSRVD | 246 | Q06210 | |
| SKKRATKAKNTGQRG | 261 | Q9H5J8 | |
| NGAEKKRKRTSIAAP | 341 | Q12837 | |
| ALEQISKGKATGRKA | 61 | Q13635 | |
| KTGRRKKDGVANAEA | 666 | Q14940 | |
| NKVRKFVAKDSAGLR | 2466 | O75592 | |
| KTGSKGTKAQRARQL | 316 | Q8N5C6 | |
| SSLKKGGRLVEKRQA | 216 | P98171 | |
| RAKSKKIEATRCSAG | 176 | Q14CN2 | |
| SLRDAGKSQQGAKKA | 691 | Q32MQ0 | |
| AIQLAKEKKQRGAGS | 721 | Q2QGD7 | |
| KRTDKSAVSGAIRLK | 1331 | Q8NB66 | |
| EGTGTNKKVAKRNAA | 331 | O95793 | |
| TGRKGLTSKERKTQA | 556 | Q9UJ98 | |
| SKAKAKAQRAGQRRE | 11 | Q96HA7 | |
| RKQERAASAKGAAGA | 146 | O14813 | |
| KGSEKAAKASRSVAG | 141 | O15014 | |
| RAQSGARKARGEAKK | 471 | Q9H8N7 | |
| VNKLRAKSRDVGSQK | 1921 | Q9UKX3 | |
| AGRKLVKTFSKGESR | 346 | O94885 | |
| GTGKRVLTAKERKTQ | 546 | Q8WVM7 | |
| AGRNALLSDISKGKK | 31 | O43516 | |
| SKRKVFDSSRARAKG | 416 | Q53FD0 | |
| GKAKRAVQRGATAVI | 141 | Q9ULT6 | |
| RAQSTAAKLGKTRLK | 81 | Q9Y2B5 | |
| SLLSKVSQGKRKRGC | 46 | Q01831 | |
| GKAAFSQEKSRRVKE | 396 | Q9UEW8 | |
| EKSKGSKRAKANTGR | 541 | Q5SRN2 | |
| SAKRGKEITGVKRQS | 541 | P40818 | |
| TENSKKAFGLIKGAR | 156 | A6NCI4 | |
| KKSREVRKSADAGSQ | 1801 | O75962 | |
| SRNKKKERQREGTGA | 106 | Q96H86 | |
| ALCAKQRTAKKAGRE | 3541 | O14686 |